Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.094 AUD | +2.17% | -6.00% | +36.23% |
Apr. 17 | Neurotech's Phase II/III NTIASD2 Clinical Trial for Children with Autism Meets Primary Endpoint | MT |
Apr. 17 | Neurotech International Completes AU$10 Million Capital Raise | MT |
- Stock Market
- Equities
- NTI Stock
- News Neurotech International Limited